![Paul Gregor](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Gregor
Directeur Général chez Rimonyx Pharmaceuticals Ltd.
Profil
Paul Gregor is the founder and the Chief Executive Officer of Romonyx Pharmaceuticals Ltd., which was founded in 2001.
He also held former positions as a Technology Director at W World Corp., a Principal at The Salk Institute for Biological Studies, Bayer Pharmaceuticals Corp., National Institutes of Health, and National Institute on Drug Abuse.
Dr. Gregor's education includes an undergraduate degree from Weizmann Institute of Science.
Postes actifs de Paul Gregor
Sociétés | Poste | Début |
---|---|---|
Rimonyx Pharmaceuticals Ltd.
![]() Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Directeur Général | 01/01/2002 |
Anciens postes connus de Paul Gregor
Sociétés | Poste | Fin |
---|---|---|
W WORL | Directeur Technique/Scientifique/R&D | - |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
The Salk Institute for Biological Studies | Corporate Officer/Principal | - |
National Institute on Drug Abuse | Corporate Officer/Principal | - |
Formation de Paul Gregor
Weizmann Institute of Science | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
W WORL | Health Technology |
Entreprise privées | 4 |
---|---|
Bayer Pharmaceuticals Corp. | |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
National Institute on Drug Abuse | Government |
Rimonyx Pharmaceuticals Ltd.
![]() Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |